Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2020 Dec 10;13:12721. doi: 10.2147/OTT.S296124

lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis [Retraction]

PMCID: PMC7735939  PMID: 33328742

Gao J, Chen Q, Zhao Y, Hou R. Onco Targets Ther. 2020;13:9225–9234.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article.

Following a review of their original data the authors found an error with the data input and statistical analysis for the expression of the CRNDE in glioblastoma multiforme (GBM) shown in Figure 1C. The cells were treated correctly, however the original data was mistakenly input and mis-calculated resulting in the incorrect values for the Relative CRNDE expression described in Figure 1C. The data no longer supports the finding that a significant difference was found when comparing relative CRNDE expression of GBM (U87, U251 and LN229) cells to NHA (Normal Human Astrocytes) cells. The authors require further investigation of this data and in the interests of scientific integrity wish to retract the published article.

The Editor has also determined the findings are no longer valid and has agreed with the authors request for the paper to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES